Iradimed (IRMD) Capital Expenditures Growth (1y) (2014 - 2026)
Iradimed (IRMD) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -6.52% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | -92.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -92.98% |
| Mar 31, 2026 | -89.10% |
| Dec 31, 2025 | -89.46% |
| Sep 30, 2025 | -70.14% |
| Jun 30, 2025 | 120.31% |
| Mar 31, 2025 | 1,675.38% |
| Dec 31, 2024 | 144.00% |
| Sep 30, 2024 | 1,136.67% |
| Jun 30, 2024 | -81.42% |
| Mar 31, 2024 | 29.27% |
| Dec 31, 2023 | -2,556.83% |
| Sep 30, 2023 | 59.67% |
| Jun 30, 2023 | 3,314.64% |
| Mar 31, 2023 | -12.14% |
| Dec 31, 2022 | 295.75% |
| Sep 30, 2022 | -33.67% |
| Jun 30, 2022 | 220.75% |
| Mar 31, 2022 | 340.59% |
| Dec 31, 2021 | 15.22% |
| Sep 30, 2021 | 28.29% |